{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:41:13Z","timestamp":1758397273602},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[1983,6,1]],"date-time":"1983-06-01T00:00:00Z","timestamp":423273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1983,6]]},"DOI":"10.1007\/bf01487336","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T06:47:31Z","timestamp":1113461251000},"page":"579-592","source":"Crossref","is-referenced-by-count":5,"title":["Zusammenh\ufffdnge zwischen Serum-Lipoproteinstoffwechsel und bili\ufffdrem Lipidstoffwechsel"],"prefix":"10.1007","volume":"61","author":[{"given":"Ottmar","family":"Lei\ufffd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl","key":"CR1","first-page":"1","volume":"492","author":"J Ahlberg","year":"1979","unstructured":"Ahlberg J (1979) Biliary lipid metabolism in hyperlipoproteinaemia and gallstone disease. Acta Chir Scand [Suppl] 492:1?32","journal-title":"Acta Chir Scand"},{"issue":"Suppl","key":"CR2","first-page":"1","volume":"643","author":"E Andersen","year":"1980","unstructured":"Andersen E (1980) On the metabolism of cholesterol and bile acids in normo-and hyperlipidaemic subjects. Acta Med Scand [Suppl] 643:1?35","journal-title":"Acta Med Scand"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.6261329","volume":"212","author":"MS Brown","year":"1981","unstructured":"Brown MS, Kovanen PT, Goldstein JL (1981) Regulation of plasma cholesterol by lipoprotein receptors. Science 212:628?635","journal-title":"Science"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.bi.44.070175.001313","volume":"44","author":"H Danielsson","year":"1975","unstructured":"Danielsson H, Sjoevall J (1975) Bile acid metabolism. Ann Rev Biochem 44:233?253","journal-title":"Ann Rev Biochem"},{"key":"CR5","volume-title":"Gallstones","year":"1979","unstructured":"Fisher MM, Goresky SM, Shaffer EA, Strasberg SM (eds) (1979) Gallstones. Plenum Press, New York London"},{"key":"CR6","first-page":"604","volume-title":"The metabolic basis of inherited disease","author":"DS Fredrickson","year":"1978","unstructured":"Fredrickson DS, Goldstein JL, Brown MS (1978) The familial hyperlipoproteinemias. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease, Fourth Edition. McGraw-Hill, New York, pp 604?655","edition":"Fourth Edition"},{"key":"CR7","first-page":"225","volume-title":"Progress in liver disease, Vol VI","author":"MA Goldman","year":"1979","unstructured":"Goldman MA, Schwartz CC, Swell L, Vlahcevic ZR (1979) Bile acid metabolism in health and disease. In: Popper H, Schaffner F (eds) Progress in liver disease, Vol VI. Grune and Stratton, New York San Francisco London, pp 225?242"},{"key":"CR8","first-page":"13","volume":"128","author":"SM Grundy","year":"1978","unstructured":"Grundy SM (1978) Cholesterol metabolism in man. West J Med 128:13?25","journal-title":"West J Med"},{"key":"CR9","first-page":"393","volume-title":"Metabolic control and disease","author":"RJ Havel","year":"1980","unstructured":"Havel RJ, Goldstein JL, Brown MS (1980) Lipoproteins and lipid transport. In: Bondy PK, Rosenberg LE (eds) Metabolic control and disease, 8th edition. WB Saunders, Philadelphia, pp 393?494","edition":"8th edition"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0300-5089(21)00388-6","volume":"6","author":"K Hellstroem","year":"1977","unstructured":"Hellstroem K, Einarsson K (1977) Bile acid metabolism in hyperlipoproteinaemia. Clin Gastroenterol 6:103?128","journal-title":"Clin Gastroenterol"},{"key":"CR11","first-page":"327","volume-title":"Hyperlipidemia ? diagnosis and therapy","author":"DB Hunninghake","year":"1977","unstructured":"Hunninghake DB, Probstfield JL (1977) Drug treatment of hyperlipoproteinaemia. In: Rifkind BM, Levy RI (eds) Hyperlipidemia ? diagnosis and therapy. Grune and Stratton, New York, pp 327?362"},{"key":"CR12","first-page":"696","volume-title":"Handbook of drug therapy","author":"AM Lees","year":"1979","unstructured":"Lees AM, Lees RS (1979) Agents used to treat hyperlipidemia and atherosclerosis. In: Miller RR, Greenblatt DJ (eds) Handbook of drug therapy. Elsevier, New York Amsterdam pp 696?728"},{"key":"CR13","first-page":"635","volume":"Suppl","author":"B Leijd","year":"1980","unstructured":"Leijd B (1980) Metabolism of plasma and biliary lipids in hyperlipoproteinaemia. Acta Med Scand [Suppl] 635","journal-title":"Acta Med Scand"},{"key":"CR14","first-page":"834","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"RJ Levy","year":"1980","unstructured":"Levy RJ (1980) Drugs used in the treatment of hyperlipoproteinaemias. In: Goodman Gilman A, Goodman LS, Gilman A (eds) Goodman and Gilman's the pharmacological basis of therapeutics, Sixth edition. Macmillian Publishing Co, New York, pp 834?847","edition":"Sixth edition"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1146\/annurev.bi.47.070178.003535","volume":"47","author":"LC Smith","year":"1978","unstructured":"Smith LC, Pownall HJ, Gotto AM jr (1978) The plasma lipoproteins: structure and metabolism. Ann Rev Biochem 47:751?777","journal-title":"Ann Rev Biochem"},{"key":"CR16","volume-title":"Bile acid and lipids","year":"1981","unstructured":"Paumgartner G, Stiehl A, Gerok W (eds) (1981) Bile acid and lipids. MTP Press Limited, Lancaster, England"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-2275(20)35374-8","volume":"22","author":"JJ Abrams","year":"1981","unstructured":"Abrams JJ, Grundy SM, Ginsberg H (1981) Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man. J Lipid Res 22:307?322","journal-title":"J Lipid Res"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-2275(20)35375-X","volume":"22","author":"JJ Abrams","year":"1981","unstructured":"Abrams JJ, Grundy SM (1981) Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. J Lipid Res 22:323?338","journal-title":"J Lipid Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0016-5085(75)80015-1","volume":"68","author":"RD Adler","year":"1975","unstructured":"Adler RD, Bennion LJ, Duane WC, Grundy SM (1975) Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism. Gastroenterology 68:326?334","journal-title":"Gastroenterology"},{"key":"CR20","first-page":"249","volume":"53","author":"J Ahlberg","year":"1977","unstructured":"Ahlberg J, Angelin B, Einarsson K, Hellstroem K, Leijd B (1977) Influence of deoxycholic acid on biliary lipids in man. Clin Sci Mol Med 53:249?256","journal-title":"Clin Sci Mol Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF01299828","volume":"24","author":"J Ahlberg","year":"1979","unstructured":"Ahlberg J, Angelin B, Einarsson K, Hellstroem K, Leijd B (1979) Prevalence of gallbladder disease in hyperlipoproteinaemia. Digest Dis Sci 24:459?464","journal-title":"Digest Dis Sci"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0016-5085(80)90079-7","volume":"79","author":"J Ahlberg","year":"1980","unstructured":"Ahlberg J, Angelin B, Einarsson K, Hellstroem K, Leijd B (1980) Biliary lipid composition in normo- and hyperlipoproteinemia. Gastroenterology 79:90?94","journal-title":"Gastroenterology"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-2275(20)34954-3","volume":"22","author":"J Ahlberg","year":"1981","unstructured":"Ahlberg J, Angelin B, Einarsson K (1981) Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of CA and CDCA treatment. J Lipid Res 22:410?422","journal-title":"J Lipid Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0016-5085(82)90305-5","volume":"82","author":"JJ Albers","year":"1982","unstructured":"Albers JJ, Grundy SM, Cleary PA, Small DM, Lachin J, Schoenfield LJ and the National Cooperative Gallstone Study Group (1982) National Cooperative Gallstone Study ? The effect of cheodeoxycholic acid on lipoproteins and apolipoproteins. Gastroenterology 82:638?646","journal-title":"Gastroenterology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0026-0495(80)90163-8","volume":"29","author":"E Andersen","year":"1980","unstructured":"Andersen E, Hellstroem K (1980) Influence of fat-rich versus carbohydrate-rich diets on bile acid kinetics, biliary lipids, and net steroid belance in hyperlipidemic subjects. Metabolism 29:400?409","journal-title":"Metabolism"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-2275(20)40004-5","volume":"20","author":"E Anderson","year":"1979","unstructured":"Anderson E, Hellstroem K (1979) The effect of cholesterol feeding on bile acid kinetics and biliary lipids in normolipidemic and hypertriglyceridemic subjects. J Lipid Res 20:1020?1027","journal-title":"J Lipid Res"},{"key":"CR27","first-page":"393","volume":"51","author":"B Angelin","year":"1976","unstructured":"Angelin B, Einarsson K, Helstroem K, Kallner M (1976) Elimination of cholesterol in hyperlipoproteinaemia. Clin Sci Mol Med 51:393?397","journal-title":"Clin Sci Mol Med"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0022-2275(20)40684-4","volume":"19","author":"B Angelin","year":"1978","unstructured":"Angelin B, Einarsson K, Hellstoem K, Leijd B (1978) Bile acid kinetics in relation to endogenous triglyceride metabolism in various types of hyperlipoproteinemia. J Lipid Res 19:1004?1016","journal-title":"J Lipid Res"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0022-2275(20)40685-6","volume":"19","author":"B Angelin","year":"1978","unstructured":"Angelin B, Einarsson K, Hellstroem K, Leijd B (1978) Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinaemia. J Lipid Res 19:1017?1024","journal-title":"J Lipid Res"},{"key":"CR30","first-page":"451","volume":"54","author":"B Angelin","year":"1978","unstructured":"Angelin B, Einarsson K, Leijd B (1978) Effect of chenodeoxycholic acid on serum and bilary lipids in patients with hyperlipoproteinaemia. Clin Sci Mol Med 54:451?455","journal-title":"Clin Sci Mol Med"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2362.1979.tb00921.x","volume":"9","author":"B Angelin","year":"1979","unstructured":"Angelin B, Einarsson K, Leijd B (1979) Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest 9:185?190","journal-title":"Eur J Clin Invest"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2362.1981.tb01839.x","volume":"11","author":"B Angelin","year":"1981","unstructured":"Angelin B, Einarsson K, Leijd B (1981) Clofibrate treatment and bile cholesterol saturation: short-term and long-term effects and influence of combination with chenodeoxycholic acid. Eur J Clin Invest 11:185?189","journal-title":"Eur J Clin Invest"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)39834-5","volume":"21","author":"B Angelin","year":"1980","unstructured":"Angelin B, Leijd B (1980) Effects of cholic acid on the metabolism of endogenous plasma triglyceride and on biliary lipid composition in hyperlipoproteinaemia. J Lipid Res 21:1?9","journal-title":"J Lipid Res"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(79)91414-4","volume":"I","author":"MC Bateson","year":"1979","unstructured":"Bateson MC, Igbal J (1979) Chenodeoxycholic acid, post-prandial serum-triglycerides, and HDL-cholesterol Lancet I:930","journal-title":"Lancet"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(79)90035-7","volume":"II","author":"MC Bateson","year":"1979","unstructured":"Bateson MC, Igbal J (1979) Ursodeoxycholic acid and serum lipids. Lancet II:151","journal-title":"Lancet"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF01072597","volume":"23","author":"MC Bateson","year":"1978","unstructured":"Bateson MC, Maclean D, Ross PE, Bouchier IAD (1978) Clofibrate therapy and gallstone induction. Digest Dis 23:623?628","journal-title":"Digest Dis"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/bmj.1.6121.1171","volume":"I","author":"MC Bateson","year":"1978","unstructured":"Bateson MC, Ross PE, Murison J, Bouchier IAD (1978) Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid. Br Med J I:1171?1173","journal-title":"Br Med J"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2362.1978.tb00843.x","volume":"8","author":"F Begemann","year":"1978","unstructured":"Begemann F (1978) Influence of chenodeoxycholic acid on the kinetics of endogenous triglyceride metabolism in man. Eur J Clin Invest 8:283?288","journal-title":"Eur J Clin Invest"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365527809179806","volume":"13","author":"F Begemann","year":"1978","unstructured":"Begemann F, Bandomer G, Herget HJ (1978) The influence of beta-sitosterol on biliary cholesterol saturation and bile acid kinetics in man. Scand J Gastroent 13:57?63","journal-title":"Scand J Gastroent"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/bmj.3.5879.520","volume":"III","author":"GD Bell","year":"1973","unstructured":"Bell GD, Lewis B, Petrie A, Dowling RH (1973) Serum lipids in cholclithiasis: effect of chenodeoxycholic acid therapy. Br Med J III:520?522","journal-title":"Br Med J"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJM197811232992104","volume":"299","author":"LJ Bennion","year":"1978","unstructured":"Bennion LJ, Grundy SM (1978) Risk factors for the development of cholelithiasis in man. N Engl J Med 299:1161?1167, 1221?1227","journal-title":"N Engl J Med"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.me.31.020180.000423","volume":"31","author":"IAD Bouchier","year":"1980","unstructured":"Bouchier IAD (1980) The medical treatment of gallstones. Ann Rev Med 31:59?77","journal-title":"Ann Rev Med"},{"key":"CR43","first-page":"523","volume":"16","author":"E Camarri","year":"1978","unstructured":"Camarri E, Fici F, Marcolongo R (1978) Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia. Int J Clin Pharmacol 16:523?526","journal-title":"Int J Clin Pharmacol"},{"key":"CR44","first-page":"193","volume":"29","author":"E Camarri","year":"1978","unstructured":"Camarri E, Marcolongo R, Zaccherotti L, Marini G (1978) The hypotriglyceridemic effect of chenodeoxycholic acid in type IV-hyperlipidemia. Biomedicine 29:193?198","journal-title":"Biomedicine"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-4684-0967-3_12","volume":"109","author":"LA Carlson","year":"1978","unstructured":"Carlson LA (1978) Nicotinic acid and inhibition of fat mobilizing lipolysis: present status of effects on lipid metabolism. Adv Exp Med Biol 109:225?238","journal-title":"Adv Exp Med Biol"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(73)90113-5","volume":"18","author":"LA Carlson","year":"1973","unstructured":"Carlson LA, Oro L (1973) Effect of treatment with nicotinic acid for one month on serum lipids in patients with different types of hyperlipidemia. Atherosclerosis 18:1?9","journal-title":"Atherosclerosis"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0016-5085(81)90608-9","volume":"81","author":"N Carulli","year":"1981","unstructured":"Carulli N, Ponz de Leon M, Loria P, Iori R, Rosi A, Romani M (1981) Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. Gastroenterology 81:539?546","journal-title":"Gastroenterology"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0016-5085(80)90237-1","volume":"79","author":"N Carulli","year":"1980","unstructured":"Carulli N, Ponz de Leon M, Zironi F, Jori R, Loria P (1980) Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. Gastroenterology 79:637?641","journal-title":"Gastroenterology"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-2275(20)39837-0","volume":"21","author":"N Carulli","year":"1980","unstructured":"Carulli N, Ponz de Leon M, Zironi F, Pinetti A, Smerieri A (1980) Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short term feeding of chenodeoxycholic and ursodeoxycholic acid. J Lipid Res 21:35?43","journal-title":"J Lipid Res"},{"key":"CR50","first-page":"303","volume":"26","author":"A Chait","year":"1978","unstructured":"Chait A, Albers JJ, Bierman EA (1978) Regulation of low-density lipoprotein degration by triiodothyronine. Clin Res 26:303 (Abstr)","journal-title":"Clin Res"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0026-0495(74)90091-2","volume":"23","author":"P Clifton-Bligh","year":"1974","unstructured":"Clifton-Bligh P, Miller NE, Nestel PJ (1974) Increased plasma cholesterol esterifying activity during colestipol resin therapy. Metabolism 23:437?444","journal-title":"Metabolism"},{"key":"CR52","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI106102","volume":"48","author":"WE Connor","year":"1969","unstructured":"Connor WE, Witiak DT, Stone DB (1969) Cholesterol balance and fecal neutral steroid and bile acid excretion in normal men fed dietary fats of different fatty acid composition. J Clin Invest 48:1363?1375","journal-title":"J Clin Invest"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(75)91845-0","volume":"I","author":"J Cooper","year":"1975","unstructured":"Cooper J, Geizerova H, Oliver MF (1975) Clofibrate and gallstones. Lancet I:1083","journal-title":"Lancet"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM197705262962101","volume":"296","author":"Coronary Drug Project Research Group","year":"1977","unstructured":"Coronary Drug Project Research Group (1977) Gallbladder disease as a side effect of drugs influencing lipid metabolism. N Engl J Med 296:1185?1190","journal-title":"N Engl J Med"},{"key":"CR55","first-page":"63","volume-title":"Liver and biliary disease, pathophysiology ? diagnosis ? management","author":"RC Day","year":"1979","unstructured":"Day RC, Harry DS, McIntyre N (1979) Plasma lipoproteins and the liver. In: Wright R, Alberti KGMM, Karrian S, Millward-Sadler GM (eds) Liver and biliary disease, pathophysiology ? diagnosis ? management. Saunders Company, London, pp 63?82"},{"key":"CR56","doi-asserted-by":"crossref","unstructured":"Dayton S, Pearce ML, Hashimoto S, Dixon WJ, Tomiyasu U (1969) A controlled clinical trial of a diet high in unsaturated fat ? in preventing complications of atherosclerosis. Circulation 40 [Suppl 2]","DOI":"10.1161\/01.CIR.40.1S2.II-1"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0021-9681(78)90076-0","volume":"31","author":"AE Dorr","year":"1978","unstructured":"Dorr AE, Gundersen K, Schneider JC jr, Spencer TW, Martin WB (1978) Colestipol hydrochloride in hypercholesterolemic patients ? effect on serum cholesterol and mortality. J Chron Dis 31:5?14","journal-title":"J Chron Dis"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0300-5089(21)00390-4","volume":"6","author":"RH Dowling","year":"1977","unstructured":"Dowling RH (1977) Chenodeoxyxholic acid therapy of gallstones. Clin Gastroenterol 6:141?163","journal-title":"Clin Gastroenterol"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-2275(20)39836-9","volume":"21","author":"K Einarsson","year":"1980","unstructured":"Einarsson K, Grundy SM (1980) Effects of feeding cholic acid and chenodeoxycholic acid on cholesterol absorption and hepatic secretion of of biliary lipids in man. J Lip Res 21:23?34","journal-title":"J Lip Res"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2362.1972.tb00648.x","volume":"2","author":"K Einarsson","year":"1972","unstructured":"Einarsson K, Hellstroem K (1972) The formation of bile acids in patients with three types of hyperlipoproteinaemia. Eur J Clin Invest 2:225?230","journal-title":"Eur J Clin Invest"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2362.1973.tb00361.x","volume":"3","author":"K Einarsson","year":"1973","unstructured":"Einarsson K, Hellstroem K, Kallner M (1973) The effect of clofibrate on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV. Eur J Clin Invest 3:345?351","journal-title":"Eur J Clin Invest"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2362.1974.tb00413.x","volume":"4","author":"K Einarsson","year":"1974","unstructured":"Einarsson K, Hellstroem K, Kallner M (1974) The effect of cholestyramine on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV. Eur J Clin Invest 4:405?410","journal-title":"Eur J Clin Invest"},{"key":"CR63","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1172\/JCI107876","volume":"54","author":"K Einarsson","year":"1974","unstructured":"Einarsson K, Hellstroem K, Kallner M (1974) Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinaemia. J Clin Invest 54:1301?1311","journal-title":"J Clin Invest"},{"key":"CR64","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0026-0495(74)90120-6","volume":"23","author":"K Einarsson","year":"1974","unstructured":"Einarsson K, Hellstroem K, Kallner M (1974) Effect of cholic acid feeding on bile acid kinetics and neutral fecal steroid excretion in hyperlipoproteinaemia (types II and IV). Metabolism 23:863?873","journal-title":"Metabolism"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(75)92831-7","volume":"I","author":"K Einarsson","year":"1975","unstructured":"Einarsson K, Hellstroem K, Kallner M (1975) Gallbladder disease in hyperlipoproteinaemia. Lancet I:484?487","journal-title":"Lancet"},{"key":"CR66","first-page":"613","volume":"90","author":"K Einarsson","year":"1977","unstructured":"Einarsson K, Hellstroem K, Leijd B (1977) Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV. J Lab Clin Med 90:613?622","journal-title":"J Lab Clin Med"},{"key":"CR67","first-page":"158","volume":"17","author":"WW Faloon","year":"1969","unstructured":"Faloon WW, Rubulis A, Rubert M (1969) Cholesterol lowering and fecal bile acid and neutral sterol alteration during oral neomycin. Clin Res 17:158","journal-title":"Clin Res"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0021-9150(78)90011-4","volume":"29","author":"R Fellin","year":"1987","unstructured":"Fellin R, Baggio G, Briani G, Baiocchi MR, Manzato E, Baldo G, Crepaldi G (1987) Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia. Atherosclerosis 29:241?249","journal-title":"Atherosclerosis"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0021-9150(75)90023-4","volume":"22","author":"R Fellin","year":"1975","unstructured":"Fellin R, Briani G, Ballestrieri P, Baggio G, Baiocchi MR, Crepaldi G Crepaldi G (1975) Long-term effects of colestipol (U-26,597 A) on plasma lipids in familial type II hyperbetalipoproteinaemia. Atherosclerosis 22:431?445","journal-title":"Atherosclerosis"},{"key":"CR70","first-page":"190","volume":"109","author":"MM Fisher","year":"1973","unstructured":"Fisher MM, Yousef IM (1973) Sex differences in the bile acid composition of human bile: studies in patients with and without gallstones. Can Med Assoc J 109:190?193","journal-title":"Can Med Assoc J"},{"key":"CR71","first-page":"G161","volume":"239","author":"H Fromm","year":"1980","unstructured":"Fromm H, Carlson GL, Hofmann AF, Farivar S, Amin P (1980) Metabolism in man of 7-ketolithocholic acid: precursor of cheno- and ursodeoxycholic acids. Am J Physiol 239:G161-G166","journal-title":"Am J Physiol"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/ajcn\/32.7.1363","volume":"32","author":"HE Gallo-Torres","year":"1979","unstructured":"Gallo-Torres HE, Miller ON, Hamilton JG (1979) Some effects of deoxycholate administration on the metabolism of cholesterol in man. Am J Clin Nutr 32:1363?1375","journal-title":"Am J Clin Nutr"},{"key":"CR73","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3181\/00379727-107-26565","volume":"107","author":"W Gamble","year":"1961","unstructured":"Gamble W, Wright LD (1961) Effect of nicotinic acid and related compounds on incorporation of mevalonic acid into cholesterol. Proc Soc Exp Biol Med 107:160?162","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(75)90835-1","volume":"II","author":"A Gerolami","year":"1975","unstructured":"Gerolami A, Sarles H (1975) Beta-sitosterol and chenodeoxycholic acid in the treatment of cholesterol gallstones. Lancet II:721","journal-title":"Lancet"},{"key":"CR75","unstructured":"Gey KF, Carlson LA (eds) Metabolic effects of nicotinic acid and its derivatives. Hans Huber Pub, Bern"},{"key":"CR76","first-page":"745","volume-title":"Blood lipids and lipoproteins","author":"JA Glomset","year":"1972","unstructured":"Glomset JA (1972) Plasma lecithin: cholesterol acyltransferase. In: Nelson GJ (editor) Blood lipids and lipoproteins. John Wiley & Sons, Inc, New York, pp 745?788"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJM197911153012001","volume":"301","author":"AP Goldberg","year":"1979","unstructured":"Goldberg AP, Appelbaum-Bowden DM, Bierman EL, et al (1979) Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. N Engl J Med 301:1073?1076","journal-title":"N Engl J Med"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archinte.1960.00270160010003","volume":"105","author":"GA Goldsmith","year":"1960","unstructured":"Goldsmith GA, Hamilton JG, Miller NO (1960) Lowering of serum lipid concentrations. Mechanisms used by unsaturated fats, nicotinic acid and neomycin: excretion of sterols and bile acids. Arch Intern Med 105:512?517","journal-title":"Arch Intern Med"},{"key":"CR79","volume-title":"Lipoproteine und Herzinfarkt. Neue Aspekte in Diagnostik und Therapie von Hyperlipidaemien","author":"H Greten","year":"1979","unstructured":"Greten H, Lang PD, Schettler G (eds) (1979) Lipoproteine und Herzinfarkt. Neue Aspekte in Diagnostik und Therapie von Hyperlipidaemien. Verlag Gerhard Witzstrock, Baden-Baden K\u00f6ln New York"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2362.1979.tb00919.x","volume":"9","author":"SM Grundy","year":"1979","unstructured":"Grundy SM (1979) Biliary lipids, gallstones and treatment of hyperlipoproteinemia. Eur J Clin Invest 9:179?180","journal-title":"Eur J Clin Invest"},{"key":"CR81","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-2275(20)39388-3","volume":"13","author":"SM Grundy","year":"1972","unstructured":"Grundy SM, Ahrens EH jr, Salen G, Schreibmann PH, Nestel PJ (1972) Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. J Lipid Res 13:531?551","journal-title":"J Lipid Res"},{"key":"CR82","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1172\/JCI107130","volume":"51","author":"SM Grundy","year":"1972","unstructured":"Grundy SM, Metzger AL, Adler RD (1972) Mechanisms of lithogenic bile formation in american indian women with cholesterol gallstones. J Clin Invest 51:3026?3043","journal-title":"J Clin Invest"},{"key":"CR83","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/978-3-642-66323-9_15","volume-title":"Lipoprotein metabolism","author":"SM Grundy","year":"1976","unstructured":"Grundy SM, Mok HYI (1976) Effects of low dose phytosterols on cholesterol adsoprtion in man. In: Greten H (editor) Lipoprotein metabolism. Springer, Berlin Heidelberg New York, pp 112?118"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-2275(20)34737-4","volume":"22","author":"SM Grundy","year":"1981","unstructured":"Grundy SM, Mok HYI, Zech L, Berman M (1981) Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res 22:24?36","journal-title":"J Lipid Res"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00003495-198019030-00001","volume":"19","author":"RC Heel","year":"1980","unstructured":"Heel RC, Brogden RN, Pakes GE, Speight TM, Avery GS (1980) Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia. Drugs 19:161?180","journal-title":"Drugs"},{"key":"CR86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0026-0495(81)90221-3","volume":"30","author":"FR Heller","year":"1981","unstructured":"Heller FR, Desager JP, Harvengt C (1981) Plasma lipid concentrations and lecithin: cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol. Metabolism 30:67?71","journal-title":"Metabolism"},{"key":"CR87","first-page":"666","volume":"63","author":"K Hellstroem","year":"1964","unstructured":"Hellstroem K, Lindstedt S (1964) Cholic-acid turnover and biliary bile acid composition in humans with abnormal thyroid function. J Lab Clin Med 63:666?679","journal-title":"J Lab Clin Med"},{"key":"CR88","first-page":"236","volume":"49","author":"NE Hoffman","year":"1974","unstructured":"Hoffman NE, Hofmann AF, Thistle JL (1974) Effect of bile acid feeding on cholesterol metabolism in gallstone patients. Mayo Clin Proc 49:236?23","journal-title":"Mayo Clin Proc"},{"key":"CR89","volume-title":"Chenodeoxycholic Acid Therapy of Gallstones ? Progress Report 1975","year":"1975","unstructured":"Hofmann AF, Paumgartner G (eds) (1975) Chenodeoxycholic Acid Therapy of Gallstones ? Progress Report 1975. Schattauer, Stuttgart"},{"key":"CR90","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/00365527709180940","volume":"12","author":"R Kadziolka","year":"1977","unstructured":"Kadziolka R, Nilsson S, Schersten T (1977) Prevalence of hyperlipoproteinemia in mean with gallstone disease. Scand J Gastroent 12:353?355","journal-title":"Scand J Gastroent"},{"key":"CR91","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJM198101293040502","volume":"304","author":"JP Kane","year":"1981","unstructured":"Kane JP, Mallory MJ, Tun P, Phillips NR, Freedman DD, Williams ML, Rowe JS, Havel RJ (1981) Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen. N Engl J Med 304:251?258","journal-title":"N Engl J Med"},{"key":"CR92","first-page":"595","volume":"86","author":"M Kallner","year":"1975","unstructured":"Kallner M (1975) The effect of chenodeoxycholic acid feeding on bile acid kinetics and fecal neutral steroid excretion in patients with hyperlipoproteinaemia types II and IV. J Lab Clin Med 86:595?604","journal-title":"J Lab Clin Med"},{"key":"CR93","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI110369","volume":"68","author":"F Kern Jr","year":"1981","unstructured":"Kern F jr, Everson GT, DeMarc B, McKinley M, Showalter R, Erfling W, Braverman DZ, Szcepanik van Leeuwen P, Klein PD (1981) Biliary lipids, bile acids, and gallbladder function in the human female. J Clin Invest 68:1229?1242","journal-title":"J Clin Invest"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2362.1974.tb00387.x","volume":"4","author":"AH Kissebah","year":"1974","unstructured":"Kissebah AH, Adams PW, Harrigan P, Wynn V (1974) The mechanism of action of clofibrate and tetranicotinylfructose (Bradilan) on the kinetics of plasma free fatty acid and triglyceride transport in type IV and type V hypertriglyceridaemia. Eur J Clin Invest 4:163?174","journal-title":"Eur J Clin Invest"},{"key":"CR95","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF01478565","volume":"56","author":"G Klose","year":"1978","unstructured":"Klose G, Mordasini R, Middelhoff G, Augustin J, Greten H (1978) Medikament\u00f6se Behandlung prim\u00e4rer Hyperlipoprotein\u00e4mien. Klin Wochenschr 56:99?110","journal-title":"Klin Wochenschr"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.CIR.40.1.13","volume":"40","author":"B Kottke","year":"1969","unstructured":"Kottke B (1969) Differences in bile acid excretion. Primary hypercholesteremia compared to combined hypercholesteremia and hypertriglyceridemia. Circulation 40:13?20","journal-title":"Circulation"},{"key":"CR97","first-page":"231","volume":"19","author":"K Kutz","year":"1981","unstructured":"Kutz K, Schulze A (1981) Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate. Z Gastroenterol 19:231?236","journal-title":"Z Gastroenterol"},{"key":"CR98","first-page":"95","volume":"92","author":"H Lageder","year":"1980","unstructured":"Lageder H (1980) Vergleichende Doppelblinduntersuchung von Bezafibrat und Clofibrat bei Patienten mit primaerer Hyperlipoprotein\u00e4mie. Wien Klin Wochenschr 92:95?101","journal-title":"Wien Klin Wochenschr"},{"key":"CR99","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0016-5085(77)80317-X","volume":"72","author":"NF Russo La","year":"1977","unstructured":"La Russo NF, Szczepanik PA, Hofmann AF (1977) Effect of deoxycholic acid ingestion on bile acid metabolism and biliary lipid secretion in normal subjects. Gastroenterology 72:132?140","journal-title":"Gastroenterology"},{"key":"CR100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-642-66323-9_16","volume-title":"Lipoprotein metabolism","author":"RS Lees","year":"1976","unstructured":"Lees RS, Lees AM (1976) Effects of sitosterol therapy on plasma lipid and lipoprotein concentrations. In: Greten H (ed) Lipoprotein metabolism, Springer, Berlin Heidelberg New York, pp 119?124"},{"key":"CR101","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0021-9150(77)90180-0","volume":"28","author":"AM Lees","year":"1977","unstructured":"Lees AM, Mok HYI, Lees RS, McCluskey MA, Grundy SM (1977) Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholestrolemia and studies of sterol balance. Atherosclerosis 28:325?338","journal-title":"Atherosclerosis"},{"key":"CR102","first-page":"247","volume-title":"Bile acids and lipids","author":"O Lei\u00df","year":"1981","unstructured":"Lei\u00df O, Bosch T, von Bergmann K (1981) Effects of bile acid feeding on lipoprotein concentration, change in cholesterol synthesis and biliary lipid secretion in patients with radiolucent gallstones. In: Paumgartner G, Stiehl A, Gerok W (eds) Bile acids and lipids. MTP Press, Lancaster, pp 247?253"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/00365528209181063","volume":"17","author":"O Lei\u00df","year":"1982","unstructured":"Lei\u00df O, von Bergmann K (1982) Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentration in patients with radiolucent gallstones. Scand J Gastroenterol 17:587?592","journal-title":"Scand J Gastroenterol"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ajcn\/12.6.421","volume":"12","author":"GA Leveille","year":"1963","unstructured":"Leveille GA, Powell RC, Sauberlich HE, et al (1963) Effect of orally and parenterally administered neomycin on plasma lipids of human subjects. Am J Clin Nutr 12:421?426","journal-title":"Am J Clin Nutr"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/0003-4819-79-1-51","volume":"79","author":"RI Levy","year":"1973","unstructured":"Levy RI, Frederickson DS, Stone NJ, et al. (1973) Cholestyramine in type II hyperlipoproteinemia ? a double-blind trial. Ann Intern Med 79:51?58","journal-title":"Ann Intern Med"},{"key":"CR106","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/bmj.1.5955.438","volume":"I","author":"TS Low-Beer","year":"1975","unstructured":"Low-Beer TS, Pomare EW (1975) Can colonic bacterial metabolites predispose to cholesterol gall stones? Br Med J I:438?440","journal-title":"Br Med J"},{"key":"CR107","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1172\/JCI110365","volume":"68","author":"RW Mahley","year":"1981","unstructured":"Mahley RW, Hui DY, Innerarity TL, Weisgraber K (1981) Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B, E and apo-E receptors. J Clin Invest 68:1197?1206","journal-title":"J Clin Invest"},{"key":"CR108","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2362.1980.tb00040.x","volume":"10","author":"PN Maton","year":"1980","unstructured":"Maton PN, Ellis HJ, Higgins MJP, Dowling RH (1980) Hepatic HMG CoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids. Eur J Clin Invest 10:325?332","journal-title":"Eur J Clin Invest"},{"key":"CR109","first-page":"851","volume":"II","author":"DP Maugdal","year":"1978","unstructured":"Maugdal DP, Bird R, Blackwood WS, Northfield TC (1978) Low-cholesterol diet: enhancement of effect of CDCA in patients with gall stones. Br Med J II:851?853","journal-title":"Br Med J"},{"key":"CR110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000403020","volume-title":"Problems in intrahepatic cholestasis","author":"N McIntyre","year":"1979","unstructured":"McIntyre N, Agorastos J, Owen JS, Harry DS (1979) The effect of cholestasis on plasma lipids and lipoproteins. In: Gentilini P, Popper H, Sherlock S, Teodori U (eds) Problems in intrahepatic cholestasis Karger, Basel, pp 116?120"},{"key":"CR111","first-page":"503","volume":"17","author":"H Micheli","year":"1979","unstructured":"Micheli H, Pometta D, Gustafson A (1979) Treatment of hyperlipoproteinemia type IIa with a new phenoxy-isobutiric acid derivative, procetofene. Int J Clin Pharmacol 17:503?506","journal-title":"Int J Clin Pharmacol"},{"key":"CR112","first-page":"917","volume":"87","author":"G Middelhoff","year":"1981","unstructured":"Middelhoff G, Loeser B, Stiehl A, Greten H (1981) Bindung von Gallens\u00e4uren an HDL: Korrelation zu cholestatischen Lebererkrankungen. Verh Dtsch Ges Inn Med 87:917?920","journal-title":"Verh Dtsch Ges Inn Med"},{"key":"CR113","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0009-8981(68)90383-5","volume":"20","author":"TA Miettinen","year":"1968","unstructured":"Miettinen TA (1968) Effect of nicotinic acid on catabolism and synthesis of cholesterol in man. Clin Chim Acta 20:43?51","journal-title":"Clin Chim Acta"},{"key":"CR114","first-page":"537","volume":"71","author":"TA Miettinen","year":"1968","unstructured":"Miettinen TA (1968) Mechanism of serum cholesterol reduction by thyroid hormones in hypothyroidism. J Lab Clin Med 71:537?547","journal-title":"J Lab Clin Med"},{"key":"CR115","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0024-3205(69)90007-1","volume":"8","author":"TA Miettinen","year":"1969","unstructured":"Miettinen TA (1969) Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo. Life Sci 8:713?721","journal-title":"Life Sci"},{"key":"CR116","first-page":"77","volume":"283","author":"TA Miettinen","year":"1973","unstructured":"Miettinen TA (1973) Effect of drugs on bile acid and cholesterol excretion. Excerpta Med Int Congr Ser 283:77?89","journal-title":"Excerpta Med Int Congr Ser"},{"key":"CR117","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1172\/JCI109607","volume":"64","author":"TA Miettinen","year":"1979","unstructured":"Miettinen TA (1979) Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects. J Clin Invest 64:1485?1493","journal-title":"J Clin Invest"},{"key":"CR118","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-2275(20)38144-X","volume":"23","author":"TA Miettinen","year":"1982","unstructured":"Miettinen TA (1982) Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. J Lipid Res 23:466?473","journal-title":"J Lipid Res"},{"key":"CR119","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.0954-6820.1967.tb10890.x","volume":"182","author":"TA Miettinen","year":"1967","unstructured":"Miettinen TA, Pelkonen R, Nikkilae EA, Heinonen O (1967) Low excretion of fecal bile acids in a family with hypercholesterolemia. Acta Med Scand. 182:645?650","journal-title":"Acta Med Scand"},{"key":"CR120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2362.1976.tb00546.x","volume":"6","author":"JP Miller","year":"1976","unstructured":"Miller JP (1976) Lecithin: cholesterol acyltransferase activity and cholestyramine resin therapy in man. Eur J Clin Invest 6:477?479","journal-title":"Eur J Clin Invest"},{"key":"CR121","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.5694\/j.1326-5377.1973.tb111068.x","volume":"1","author":"NE Miller","year":"1973","unstructured":"Miller NE, Clifton-Bligh P, Nestel P, Whyte HM (1973) Controlled clinical trial of a new bile acid sequestering resin, colestipol, in the treatment of hypercholesterolemia. Med J Aust 1:1223?1227","journal-title":"Med J Aust"},{"key":"CR122","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(74)91134-9","volume":"II","author":"NE Miller","year":"1974","unstructured":"Miller NE, Nestel PJ (1974) Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia. Lancet II:929?931","journal-title":"Lancet"},{"key":"CR123","first-page":"177","volume-title":"Hyperlipidemia ? Diagnosis and therapy","author":"M Mishkel","year":"1977","unstructured":"Mishkel M, Stein EA (1977) Primary type IV-hyperlipoproteinemia. In: Rifkind BM, Levy RI (eds) Hyperlipidemia ? Diagnosis and therapy. Grune and Stratton New York, pp 177?203"},{"key":"CR124","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1016\/S0021-9258(19)42217-5","volume":"249","author":"KA Mitropoulos","year":"1974","unstructured":"Mitropoulos KA, Myant NB, Gibbon GF, Balasubramaniam S, Reeves BEA (1974) Cholesterol precursor pools for the synthesis of cholic and chenodeoxycholic acids in rats. J Biol Chem 249:6052?6056","journal-title":"J Biol Chem"},{"key":"CR125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0016-5085(80)90193-6","volume":"78","author":"HYI Mok","year":"1980","unstructured":"Mok HYI, Grundy SM (1980) Cholesterol and bile acid absorption during bile acid therapy in obese subjects undergoing weight reduction. Gastroenterology 78:62?67","journal-title":"Gastroenterology"},{"key":"CR126","first-page":"1140","volume":"109","author":"R Mordasini","year":"1979","unstructured":"Mordasini R, Grandjean EM, Nobile PC, Paumgartner G, Riva G (1979) Procetofen ? eine Alternative in der Behandlung der Hypercholesterin\u00e4mie? Schweiz Med Wochenschr 109:1140?1143","journal-title":"Schweiz Med Wochenschr"},{"key":"CR127","first-page":"95","volume":"112","author":"R Mordasini","year":"1982","unstructured":"Mordasini R, Riesen W, Oster P, Riva G (1982) Verhalten der High-density-Lipoproteine (HDL) unter medikament\u00f6ser lipidsenkender Behandlung. Schweiz Med Wochenschr 112:95?97","journal-title":"Schweiz Med Wochenschr"},{"key":"CR128","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM197604082941507","volume":"294","author":"G Motulsky","year":"1976","unstructured":"Motulsky G (1976) Current concepts in genetics: the genetic hyperlipidemias. N Engl J Med 294:823?827","journal-title":"N Engl J Med"},{"key":"CR129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2362.1972.tb00649.x","volume":"2","author":"EA Nikkilae","year":"1972","unstructured":"Nikkilae EA, Kekki M (1972) Plasma endogenous triglyceride traansport in hypertriglyceriademia and effect of a hypolipidaemic drug (SU-13437). Eur J Clin Invest 2:231?238","journal-title":"Eur J Clin Invest"},{"key":"CR130","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1172\/JCI107017","volume":"51","author":"EA Nikkila","year":"1972","unstructured":"Nikkila EA, Kekki M (1972) Plasma triglyceride metabolism in thyroid desease. J Clin Invest 51:2103?2114","journal-title":"J Clin Invest"},{"key":"CR131","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1445-5994.1974.tb03223.x","volume":"4","author":"PJ Nestel","year":"1974","unstructured":"Nestel PJ, Hunter JD (1974) Differences in bile acid excretion in subjects with hypercholesterolaemia, hypertriglyceriademia and overweight. Austr N Zealand J Med 4:491?496","journal-title":"Austr N Zealand J Med"},{"key":"CR132","first-page":"621","volume":"49","author":"PJ Nestel","year":"1975","unstructured":"Nestel PJ, Kudchodkar B (1975) Plasma squalene as an index of cholesterol synthesis. Clin Sci Mol Med 49:621?624","journal-title":"Clin Sci Mol Med"},{"key":"CR133","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0021-9150(78)90093-X","volume":"29","author":"AG Olsson","year":"1978","unstructured":"Olsson AG, Dairou F (1978) Acute effects of cholestyramine on serum lipoprotein concentrations in type II hyperlipoproteinaemia. Atherosclerosis 29:53?61","journal-title":"Atherosclerosis"},{"key":"CR134","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0021-9150(78)90137-5","volume":"31","author":"AG Olsson","year":"1978","unstructured":"Olsson AG, Lang PD (1978) Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia. Atherosclerosis 31:421?428","journal-title":"Atherosclerosis"},{"key":"CR135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0021-9150(78)90138-7","volume":"31","author":"AG Olson","year":"1978","unstructured":"Olson AG, Lang PD (1978) One-year study of the effect of bezafibrate on serum lioporotein concentrations in hyperlipoproteinaemia. atherosclerosis 31:429?433","journal-title":"atherosclerosis"},{"key":"CR136","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-642-66323-9_17","volume-title":"Lipoprotein metabolism","author":"P Oster","year":"1976","unstructured":"Oster P, Schlierf G, Heuck C, Greten H, Gundert-Remy U, Haase W, Klose G, Nothelfer A, Raetzer H, Schellenberg B (1976) Sitosterol in type II hyperliporoteinemia. In: Greten H (editor) Lipoprotein metabolism. Springer, Berlin Heidelberg New York, pp 125?130"},{"key":"CR137","first-page":"424","volume":"91","author":"RH Palmer","year":"1978","unstructured":"Palmer RH (1978) Prevalence of gallstones in hyperlipidemia and incidence during treatment with clofibrate and\/or cholestyramine. Trans Assoc Am Physicians 91:424?432","journal-title":"Trans Assoc Am Physicians"},{"key":"CR138","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0300-5089(21)00218-2","volume":"8","author":"BJ Pearlman","year":"1979","unstructured":"Pearlman BJ, Marks JW, Bonorris GG, Schoenfield LJ (1979) Gallstone dissolution ? a progress report. Clin Gastroenterol 8:123?140","journal-title":"Clin Gastroenterol"},{"key":"CR139","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/00365521.1974.12096913","volume":"9","author":"L Pederson","year":"1974","unstructured":"Pederson L, Arnfred T, Thaysen HE (1974) Cholesterol kinetics in patients with cholesterol gallstones before and during chenodeoxycholic acid treatment. Scand J Gastroent 9:787?792","journal-title":"Scand J Gastroent"},{"key":"CR140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0016-5085(74)80045-4","volume":"66","author":"D Pertsemlidis","year":"1974","unstructured":"Pertsemlidis D, Panveliwalla D, Ahrens EH jr (1974) Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology 66:565?573","journal-title":"Gastroenterology"},{"key":"CR141","series-title":"Monographs on atherosclerosis","volume-title":"Sitosterol","author":"OJ Pollak","year":"1981","unstructured":"Pollak OJ, Kritchevsky D (1981) Sitosterol. Monographs on atherosclerosis, Vol 10. Karger, Basel M\u00fcnchen Paris London New York Sidney"},{"key":"CR142","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/gut.14.11.885","volume":"14","author":"EW Pomare","year":"1973","unstructured":"Pomare EW, Heaton KW (1973) Bile salt metabolism in patients with gallstones in functioning gallbladders. Gut 14:885?890","journal-title":"Gut"},{"key":"CR143","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0016-5085(79)90269-5","volume":"77","author":"M Ponz de Leon","year":"1979","unstructured":"Ponz de Leon M, Carulli N, Loria P (1979) The effect of chendoeoxycholic acid (CDCA) on cholesterol absorption. Gastroenterology 77:223?230","journal-title":"Gastroenterology"},{"key":"CR144","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0016-5085(80)90567-3","volume":"78","author":"M Ponz de Leon","year":"1980","unstructured":"Ponz de Leon M, Carulli N, Loria P, Iori R, Zironi F (1980) Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration. Gastroenterology 78:214?219","journal-title":"Gastroenterology"},{"key":"CR145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ajcn\/11.2.156","volume":"11","author":"RC Powell","year":"1962","unstructured":"Powell RC, Nunes WT, Harting RS, et al (1962) The influences of nonabsorbable antibiotics on serum lipids and the excretion of neutral sterols and bile acids. Am J Clin Nutr 11:156?168","journal-title":"Am J Clin Nutr"},{"key":"CR146","doi-asserted-by":"crossref","unstructured":"Report from Committee of Principal Investigators (1978) A co-operative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 40:1069?1118","DOI":"10.1136\/hrt.40.10.1069"},{"key":"CR147","first-page":"135","volume-title":"International Conference on Atherosclerosis","author":"S Roessner","year":"1978","unstructured":"Roessner S, Oreo L (1978) Effects on serum lipoproteins of procetofene in hyperlipoproteinemia: dose-response studies and comparison with clofibrate. In: Carlson LA (editor) International Conference on Atherosclerosis. Raven Press, New York, pp 135?140"},{"key":"CR148","first-page":"117","volume":"25","author":"SM Sabesin","year":"1980","unstructured":"Sabesin SM, Bertram PD, Freeman MR (1980) Lipoprotein metabolism in liver disease. Adv Inter Med 25:117?146","journal-title":"Adv Inter Med"},{"key":"CR149","first-page":"243","volume-title":"Progress in liver disease, Vol VI","author":"SM Sabesin","year":"1979","unstructured":"Sabesin SM, Ragland JB, Freeman MR (1979) Lipoprotein disturbances in liver disease. In: Popper H, Schaffner F (eds) Progress in liver disease, Vol VI. Grune and Straton, New York San Francisco London, pp 243?262"},{"key":"CR150","first-page":"44","volume":"57","author":"C Sama","year":"1982","unstructured":"Sama C, LaRusso NF (1982) Effect of deoxycholic, chenodeoxycholic, and cholic acids on intestinal absorption of cholesterol in humans. Mayo Clinic Proc 57:44?50","journal-title":"Mayo Clinic Proc"},{"key":"CR151","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/01.CIR.35.5.938","volume":"35","author":"P Samuel","year":"1967","unstructured":"Samuel P, Holtzman CM, Goldstein BS (1967) Long term reduction of serum cholesterol levels of patients with atherosclerosis by small doses of neomycin. Circulation 35:938?945","journal-title":"Circulation"},{"key":"CR152","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3181\/00379727-100-24569","volume":"100","author":"P Samuel","year":"1959","unstructured":"Samuel P, Steiner A (1959) Effect of neomycin on serum cholesterol level of man. Proc Soc Exp Biol Med 100:193?195","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR153","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF01727456","volume":"44","author":"F Sandhofer","year":"1966","unstructured":"Sandhofer F, Sailer S, Braunsteiner H (1966) Plasmalipide bei St\u00f6rungen der Schilddr\u00fcsenfunktion. Klin Wochenschr 44:433?436","journal-title":"Klin Wochenschr"},{"key":"CR154","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0021-9150(80)90213-0","volume":"36","author":"G Schlierf","year":"1980","unstructured":"Schlierf G, Chwat M, Feuerborn E, W\u00fclfinghof E, Heuck CC, Kohlmeier M, Oster P, Stiehl A (1980) Biliary and plasma lipids and lipid-lowering chemotherapy ? studies with clofibrate, fenofibrate and etofibrate in healthy volunteers. Atherosclerosis 36:323?329","journal-title":"Atherosclerosis"},{"key":"CR155","first-page":"165","volume":"122","author":"G Schlierf","year":"1980","unstructured":"Schlierf G, Fischer H, Roche A, Stiehl A, Oster P, Schellenberg B, Vollmar J (1980) Gallenlipide unter Bezafibrat. Muench Med Wochenschr 122:165?168","journal-title":"Muench Med Wochenschr"},{"key":"CR156","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0021-9150(78)90116-8","volume":"30","author":"G Schlierf","year":"1978","unstructured":"Schlierf G, Oster P, Heuck CC, Raetzer H, Schellenberg B (1978) Sitosterol in juvenile type II hyperlipoproteincmia. Atherosclerosis 30:245?248","journal-title":"Atherosclerosis"},{"key":"CR157","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1126\/science.204996","volume":"200","author":"CC Schwartz","year":"1978","unstructured":"Schwartz CC, Halloran LG, Vlahcevic ZR, Gregory DH, Swell L (1978) Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man. Science 200:62?64","journal-title":"Science"},{"key":"CR158","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1172\/JCI108952","volume":"61","author":"CC Schwartz","year":"1978","unstructured":"Schwartz CC, Bermann M, Vlahcevic ZR, Halloran LG, Gregory DH (1978) Multicompartmental analysis of cholesterol metabolism in man: characterization of the hepatic bile acid and biliary cholesterol precursor sites. J Clin Invest 61:408?423","journal-title":"J Clin Invest"},{"key":"CR159","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI107902","volume":"55","author":"A Sedaghat","year":"1975","unstructured":"Sedaghat A, Samuel P, Crouse JR, Ahrens EH jr (1975) Effects of neomycin on absorption, synthesis, and\/or flux of cholesterol in man. J Clin Invest 55:12?21","journal-title":"J Clin Invest"},{"key":"CR160","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF01482530","volume":"55","author":"D Seidel","year":"1977","unstructured":"Seidel D (1977) Studien zur Charakterisierung und zum Stoffwechsel des Lipoprotein-X (Lp-X), des abnormen Lipoproteins der Cholestase. Klin Wochenschr 55:611?623","journal-title":"Klin Wochenschr"},{"key":"CR161","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM198005293022202","volume":"302","author":"J Shepherd","year":"1980","unstructured":"Shepherd J, Packard CJ, Bicker S, Veitch Lawrie TD, Morgan HG (1980) Cholestyramine promotes receptormediated low-density-lipoprotein catabolism. N Engl J Med 302:1219?1222","journal-title":"N Engl J Med"},{"key":"CR162","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0021-9150(79)90036-4","volume":"33","author":"J Shepherd","year":"1979","unstructured":"Shepherd J, Packard CJ, Morgan HG, Third JLHC, Steward JM, Lawrie TDV (1979) The effects of cholestyramine on high density lipoprotein metabolism. Atherosclerosis 33:433?444","journal-title":"Atherosclerosis"},{"key":"CR163","first-page":"89","volume-title":"Liver and bile","author":"DM Small","year":"1977","unstructured":"Small DM (1977) Bile salts of the blood. High density lipoprotein systems and cholesterol removal. In: Bianchi L, Gerok W, Sickinger K (eds) Liver and bile. MTP Press Ltd, Lancaster, pp 89?100"},{"key":"CR164","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-4615-7064-6_7","volume-title":"Gallstones","author":"DM Small","year":"1979","unstructured":"Small DM, Atkinson D, Redgrave T, Shipley GG, Tall AR (1979) A biophysical approach to cholesterol transport from tissues to bile In: Fisher MM, Goresky CA, Shaffer EA, Strasberg SM (eds) Gallstones. Plenum Press New York Long, pp 113?129"},{"key":"CR165","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1172\/JCI109012","volume":"61","author":"A Sniderman","year":"1978","unstructured":"Sniderman A, Thomas D, Marpole D, Teng B (1978) Low density lipoprotein. A metabolic pathway for return of cholesterol to the splanchnic bed. J Clin Invest 61:867?87","journal-title":"J Clin Invest"},{"key":"CR166","unstructured":"Stewart JM, Packard CJ, Boag DE, Lorimer AR, Shepherd J (1981) The effects of bezafibrate on low density lipoprotein (LDL) metabolism in type II hyperlipoproteinaemia. In: Lipoproteins and Coronary Ahterosclerosis, Lugano, October 1?3. Abstract Book, p 42"},{"key":"CR167","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(81)91213-7","volume":"II","author":"W Stoffel","year":"1981","unstructured":"Stoffel W, Borberg H, Greve V (1981) Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet II:1005?1007","journal-title":"Lancet"},{"key":"CR168","first-page":"113","volume-title":"Hyperlipidemia ? diagnosis and therapy","author":"NJ Stone","year":"1977","unstructured":"Stone NJ (1977) Primary type II-hyperlipoproteinemia. In: Rifkind BM, Levy RI (eds) Hyperlipidemia ? diagnosis and therapy. Grune and Stratton, New York, pp 113?136"},{"key":"CR169","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM197301042880106","volume":"288","author":"RAL Sturdevant","year":"1973","unstructured":"Sturdevant RAL, Pearce ML, Dayton S (1973) Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. N Engl J Med 288:24?27","journal-title":"N Engl J Med"},{"key":"CR170","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0016-5085(79)90398-6","volume":"76","author":"TN Tangedahl","year":"1979","unstructured":"Tangedahl TN, Thistle JL, Hofmann AF, Kottke BA (1979) Effect of beta-sitosterol alone or in combination with chenic acid on cholesterol saturation of bile and cholesterol absorption in gallstone patients. Gastroenterology 76:1341?1346","journal-title":"Gastroenterology"},{"key":"CR171","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-2275(20)40658-3","volume":"20","author":"TN Tangedahl","year":"1979","unstructured":"Tangedahl TN, Hofmann AF, Kottke BA (1979) Biliary lipid secretion in hypercholesterolemia. J Lipid Res 20:125?133","journal-title":"J Lipid Res"},{"key":"CR172","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S0140-6736(77)90548-7","volume":"II","author":"KG Taylor","year":"1977","unstructured":"Taylor KG, Holdsworth G, Galton DJ (1977) Clofibrate increases lipoprotein-lipase activity in adipose tissue of hypertriglyceridaemic patients. Lancet II:1106?1107","journal-title":"Lancet"},{"key":"CR173","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.1972.03200070084015","volume":"220","author":"The Coronary Durg Project Research Group","year":"1972","unstructured":"The Coronary Durg Project Research Group (1972) The coronary drug project: Findings leading to further modifications of its protocol with respect to dextrothyroxine. JAMA 220:996?1008","journal-title":"JAMA"},{"key":"CR174","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","volume":"231","author":"The Coronary Drug Project Research Group","year":"1975","unstructured":"The Coronary Drug Project Research Group (1975) Coronary Drug Project. Clofibrate and niacin in coronary heart disease. JAMA 231:360?381","journal-title":"JAMA"},{"key":"CR175","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/0016-5085(78)90662-5","volume":"75","author":"JL Thistle","year":"1978","unstructured":"Thistle JL, Ott BJ, Ellefson RD (1978) Serum lipoprotein cholesterol changes during bile acid ingestion for gallstone dissolution. Gastroenterology 75:990 (Abstr)","journal-title":"Gastroenterology"},{"key":"CR176","first-page":"1103","volume":"74","author":"JL Thistle","year":"1978","unstructured":"Thistle JL, Turcott J, Ott BY, Carlson GL, LaRusso NF, Hofmann AF (1978) Ursodeoxycholic acid unsaturates bile at a lower dose than chenodeoxycholic acid. Gastroenterology 74:1103?1109","journal-title":"Gastroenterology"},{"key":"CR177","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0140-6736(81)92412-0","volume":"1","author":"GR Thompson","year":"1981","unstructured":"Thompson GR (1981) Plasma exchange for hypercholesterolaemia. Lancet 1:1246?1248","journal-title":"Lancet"},{"key":"CR178","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1172\/JCI106497","volume":"50","author":"GR Thompson","year":"1971","unstructured":"Thompson GR, Barrowman J, Gutierrez L, Dowling RH (1971) Action of neomycin on the intraluminal phase of lipid absorption. J Clin Invest 50:319?323","journal-title":"J Clin Invest"},{"key":"CR179","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/hrt.43.6.668","volume":"43","author":"GR Thompson","year":"1980","unstructured":"Thompson GR, Myant NB, Kilpatrick D, Oakley CM, Raphael HJ et al (1980) Assessment of long term plasma exchange for familial hypercholesterolacmia. Br Heart J 43:668?680","journal-title":"Br Heart J"},{"key":"CR180","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/bmj.283.6303.1352","volume":"283","author":"JR Thornton","year":"1981","unstructured":"Thornton JR, Heaton KW, Macfarlane DG (1981) A relation between high-density-lipoprotein cholesterol and bile cholesterol saturation. Br Med J 283:1352?1354","journal-title":"Br Med J"},{"key":"CR181","first-page":"465","volume":"19","author":"G Utermann","year":"1978","unstructured":"Utermann G (1978) Genetik famili\u00e4rer Hyperlipoprotein\u00e4mien. Internist 19:465?469","journal-title":"Internist"},{"key":"CR182","first-page":"97","volume":"2","author":"JF Bosch Van den","year":"1967","unstructured":"Van den Bosch JF, Claes PJ (1967) Correlation between the bile salt-precipitating capacity of derivatives of basic antibiotics and their plasma cholesterol lowering effect in vivo. Prog Biochem Pharmacol 2:97?104","journal-title":"Prog Biochem Pharmacol"},{"key":"CR183","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3109\/00365517709101859","volume":"37","author":"W Linden Van der","year":"1977","unstructured":"Van der Linden W, Bergman F (1977) An analysis of data on human hepatic bile. Relationship between main bile components, serum cholesterol and serum triglycerides. Scand J Clin Lab Invest 37:741?747","journal-title":"Scand J Clin Lab Invest"},{"key":"CR184","unstructured":"Von Bergmann K, Bosch T, Lei\u00df O (1981) Effect of different bile acid feeding on change of cholesterol synthesis in man. Hepatology 1:67C"},{"key":"CR185","first-page":"61","volume-title":"Biological effects of bile acids","author":"K Bergmann Von","year":"1979","unstructured":"Von Bergmann K, Gutsfeld M, Schulze-Hagen K, von Unruh G (1979) Effects of ursodeoxycholic acid on biliary lipid secretion in patients with radiolucent gallstones. In: Paumgartner G, Stiehl A, Gerok W (eds) Biological effects of bile acids. MTP Press Ltd, Lancaster, pp 61?66"},{"key":"CR186","unstructured":"Von Bergmann K, Lci\u00df O (1982) Effect of bezafibrate and fenofibrate on cholesterol synthesis in hyperlipidemic patients. International Symposium, Dijon, March 13?14"},{"key":"CR187","unstructured":"Von Bergmann K, Lei\u00df O, Kutz K (1981) Effects of lipid lowering substances on biliary lipid metabolism in hyperlipidaemic patients. In: Lipoproteins and Coronary Atherosclerosis, Lugano, October 1?3. Abstract Book, p 190"},{"key":"CR188","unstructured":"Von Bergmann K, Lei\u00df O (1982) Effects of different bile acids on cholesterol absorption in man. VII International Bile Acid Meeting, Basel, October 12?14"},{"key":"CR189","unstructured":"Von Bergmann K, Strottkoeter H, Lei\u00df O (1981) Decreased cholesterol absorption during ursodeoxycholic acid administration. Hepatology 1:67D"},{"key":"CR190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2362.1978.tb00869.x","volume":"8","author":"L Wallentin","year":"1978","unstructured":"Wallentin L (1978) Lecithin: cholesterol acyl transfer rate and high density lipoproteins in plasma during dietary and cholestyramine treatment of type II A hyperlipoproteinaemia. Eur J Clin Invest 8:383?389","journal-title":"Eur J Clin Invest"},{"key":"CR191","first-page":"217","volume":"29","author":"KW Walton","year":"1965","unstructured":"Walton KW, Scott PJ, Dykes PW, Davids JWL (1965) The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131-J-lowdensity lipoproteins in hypothyroidism and thyrotoxicosis. Clin Sci 29:217?238","journal-title":"Clin Sci"},{"key":"CR192","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01716387","volume":"60","author":"JG Wechsler","year":"1982","unstructured":"Wechsler JG, Hutt V, Kloer H-U, Bode G, Ditschuneit H (1982) Wirkung von Bezafibrat bei prim\u00e4ren Hyperlipid\u00e4mien. Klin Wochenschr 60:97?105","journal-title":"Klin Wochenschr"},{"key":"CR193","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0021-9150(79)90181-3","volume":"33","author":"P Weisweiler","year":"1979","unstructured":"Weisweiler P, Neureuther G, Schwandt P (1979) The effect of cholestyramine on lipoprotein lipids in patients with primary type II A hyperlipoproteinemia. Atherosclerosis 33, 295?300","journal-title":"Atherosclerosis"},{"key":"CR194","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/BF01651267","volume":"55","author":"P Weisweiler","year":"1977","unstructured":"Weisweiler P, Schwandt P (1977) Lipoproteinver\u00e4nderungen unter Clofibrat bei Typ IV-Hyperlipoprotein\u00e4mien. Klin Wochenschr 55:791?794","journal-title":"Klin Wochenschr"},{"key":"CR195","first-page":"361","volume":"178","author":"LW White","year":"1971","unstructured":"White LW (1971) Regulation of hepatic cholesterol biosynthesis by clofibrate administration. J Pharmacol Exp Ther 178:361?370","journal-title":"J Pharmacol Exp Ther"},{"key":"CR196","first-page":"15","volume":"58","author":"G Williams","year":"1979","unstructured":"Williams G, Murphy GM, Dowling RH (1979) Effect of ursodeoxycholic acid (UDCA) on serum total and VLDL triglycerides in gallstone patients. Cli Sci 58:15","journal-title":"Cli Sci"},{"key":"CR197","first-page":"1008","volume":"88","author":"JL Witztum","year":"1976","unstructured":"Witztum JL, Schonfeld G, Weidman SW (1976) The effects of colestipol on the metabolism of very-low-density lipoproteins in man. J Lab Clin Med 88:1008?1018","journal-title":"J Lab Clin Med"},{"key":"CR198","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01487773","volume":"50","author":"J Wollenweber","year":"1972","unstructured":"Wollenweber J, Stiehl A (1972) Gr\u00f6\u00dfe der Pools und Turnover der prim\u00e4ren Gallens\u00e4uren bei Hyperlipoprotein\u00e4mien: Unterschiedliche Befunde bei Typ II- und Typ IV-Hyperlipoprotein\u00e4mie. Klin Wochenschr 50:33?38","journal-title":"Klin Wochenschr"},{"key":"CR199","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0026-0495(72)90062-5","volume":"21","author":"PD Wood","year":"1972","unstructured":"Wood PD, Shioda R, Estrich EL, et al. (1972) Effect of cholestyraminc on composition of duodenal bile in obese human subjects. Metabolism 21:107?116","journal-title":"Metabolism"},{"key":"CR200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(76)90755-5","volume":"60","author":"D Yeshurun","year":"1976","unstructured":"Yeshurun D, Gotto AM (1976) Drug treatment of hyperlipidemia. Am J Med 60:379?396","journal-title":"Am J Med"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01487336\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01487336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01487336\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01487336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T17:08:05Z","timestamp":1625764085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01487336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,6]]},"references-count":200,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1983,6]]}},"alternative-id":["BF01487336"],"URL":"https:\/\/doi.org\/10.1007\/bf01487336","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,6]]}}}